Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

FDA Approves Rebinyn to Treat Hemophilia B

Novo Nordisk news release; 2018 Feb 8

The FDA has approved Rebinyn for the treatment of hemophilia B.

Indications: Rebinyn, Coagulation Factor IX (Recombinant), GlycoPEGylated, is a recombinant DNA-derived coagulation Factor IX concentrate indicated for use in adults and children with hemophilia B for:

  • On-demand treatment and control of bleeding episodes.
  • Perioperative management of bleeding.

Dosage and administration: 40 IU/kg body weight for minor and moderate bleeds/minor surgery, and 80 IU/kg body weight for major bleeds/major surgery.

Efficacy and safety: In phase 3 studies, a single dose of 40 IU/kg in adults elevated factor activity above baseline levels by 94% and sustained average factor levels of 17% 7 days post-dose. Adults also achieved an 83-hour average half-life after receiving a single infusion.

Side effects/risks: The most common adverse reactions are itching and injection site reactions.

Citation:

Novo Nordisk launches Rebinyn in the United States for people with hemophilia B. [news release]. Plainsboro, NJ: Novo Nordisk Inc. February 8, 2018. http://press.novonordisk-us.com/2018-02-08-Novo-Nordisk-Launches-Rebinyn... Accessed February 12, 2018.

Rebinyn [package insert]. Plainsboro, NJ: Novo Nordisk Inc. 2018. https://www.fda.gov/downloads/BiologicsBloodVaccines/BloodBloodProducts/.... Accessed February 12, 2018.

This Week's Must Reads

Tamibarotene vs. ATRA in APL, Source: Takeshita A et al. ASH 2017, abstract 642.

HIT Incidence During Obstetric Hospital Admissions, Am J Perinatol.; ePub 2018 Feb 8; Sagaram, et al

Endoscopy for GI Bleeds in Severe Thrombocytopenia, Gastrointest Endosc; ePub 2018 Feb 1; Ramos, et al

Does This Predict Acute Pain in Children with SCD? , Am J Hematol; ePub 2018 Jan 25; Willen, et al

Ibuprofen Use in Alcohol-Related Thrombocytopenia , Hosp Pharm; 2018 Feb; Muhammad, Tomko, et al

Must Reads in Bleeding Disorders

HIT Incidence During Obstetric Hospital Admissions, Am J Perinatol.; ePub 2018 Feb 8; Sagaram, et al

Endoscopy for GI Bleeds in Severe Thrombocytopenia, Gastrointest Endosc; ePub 2018 Feb 1; Ramos, et al

Does This Predict Acute Pain in Children with SCD? , Am J Hematol; ePub 2018 Jan 25; Willen, et al

Ibuprofen Use in Alcohol-Related Thrombocytopenia , Hosp Pharm; 2018 Feb; Muhammad, Tomko, et al

Romiplostim-Treated Patients: No Increased AML Risk, Lancet Haematol; ePub 2018 Jan 25; Kantarjian, et al